These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35681218)

  • 1. Gut metabolites predict Clostridioides difficile recurrence.
    Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
    Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
    Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
    mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional profile of host microbiome indicates
    Nzabarushimana E; Tang H
    Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection.
    Bosnjak M; Karpe AV; Van TTH; Kotsanas D; Jenkin GA; Costello SP; Johanesen P; Moore RJ; Beale DJ; Srikhanta YN; Palombo EA; Larcombe S; Lyras D
    Nat Commun; 2023 Nov; 14(1):7737. PubMed ID: 38007555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.
    Pakpour S; Bhanvadia A; Zhu R; Amarnani A; Gibbons SM; Gurry T; Alm EJ; Martello LA
    Microbiome; 2017 Nov; 5(1):148. PubMed ID: 29132405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
    mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
    Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
    BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disordered Intestinal Microbial Communities During
    Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
    Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
    Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
    Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
    Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the gut microbiome in colonization resistance and recurrent
    Seekatz AM; Safdar N; Khanna S
    Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
    Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
    J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating gut microbiome and host immune markers to understand the pathogenesis of
    Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
    [No Abstract]   [Full Text] [Related]  

  • 15. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
    Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
    Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the gut microbiome of patients with
    Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
    Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut associated metabolites and their roles in
    Aguirre AM; Sorg JA
    Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2'-Fucosyllactose inhibits proliferation of
    Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
    Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
    Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
    Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.